GlassScriptPhysician profile
Renee Good
NPI 1831893510
$620.56
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $536 · 2024: $84.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $137.42 | 2023 | Quviviq |
| Abbvie INC. | $100.13 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.55 | 2023 | |
| Paratek Pharmaceuticals, INC. | $45.18 | 2023 | Nuzyra |
| Novo Nordisk INC | $43.34 | 2023 | Rybelsus, Ozempic, Wegovy |
| Inspire Medical Systems, INC. | $41.45 | 2023 | Inspire |
| Otsuka America Pharmaceutical, INC. | $40.55 | 2023 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Axsome Therapeutics, INC. | $30.47 | 2024 | Auvelity |
| Alkermes, INC. | $28.13 | 2023 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $24.14 | 2023 | |
| Exact Sciences Corporation | $22.08 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $19.40 | 2023 | Farxiga |
| Nestle Healthcare Nutrition INC. | $14.94 | 2023 | |
| Lilly USA, LLC | $14.80 | 2023 | Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $12.98 | 2023 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Good listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.